NLS Pharmaceutics Ltd (NLSP)
0.1428
+0.01
(+4.54%)
USD |
NASDAQ |
Sep 20, 16:00
0.1451
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.0396M |
| June 30, 2021 | -0.0328M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.0396M
Minimum
Dec 2021
--
Maximum
Dec 2020
-0.0241M
Average
-0.0328M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
| AC Immune SA | -78.66M |
| CRISPR Therapeutics AG | -184.81M |
| Addex Therapeutics Ltd | -0.005M |
| Molecular Partners AG | 75.48M |
| MoonLake Immunotherapeutics | -174.06M |